Form 4 for DMAC DiaMedica Therapeutics Inc.
Accepted 2025-11-25 00:00:00 ET · period of report 2025-11-21 · accession 0001759855-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-25 | 2025-11-21 | DMAC | Parsons James T. | Dir | M - OptEx | $2.20 | +12.0K | 87.9K | +16% | +$26.4K |
| D | 2025-11-25 | 2025-11-21 | DMAC | Parsons James T. | Dir | M - OptEx | $0.00 | -12.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-21 | M | A | 12,000 | $2.20 | 87,854 | D | — | — | (F1) Represents the conversion of the exercise price from CAD$ to US$ on the transaction date. |
| 2 | Derivative | Stock Option (right to buy) | 2025-11-21 | M | D | 12,000 | $0.00 | 0 | D | $2.20 · — to 2025-12-01 | 12,000 Common Shares | (F1) Represents the conversion of the exercise price from CAD$ to US$ on the transaction date. (F2) Fully vested. |